Literature DB >> 2035825

Description of an enzyme-linked immunosorbent assay for the detection of protein tyrosine kinase.

I Lázaro1, M Gonzalez, G Roy, L M Villar, P Gonzalez-Porqué.   

Abstract

A solid immunoassay for the detection of protein tyrosine kinases has been developed. It is based on the binding of the synthetic polypeptide poly(Glu.Na,Tyr) 4:1 to microELISA wells, where the phosphorylation reaction takes place in the presence of ATP and enzyme. The phosphorylated tyrosine residues produced in the reaction are finally detected, in the same well, by means of an ELISA using monoclonal antiphosphotyrosine antibody, peroxidase-labeled goat anti-mouse IgG antibody, and substrate. The amount of protein tyrosine kinase activity present in the sample is proportional to the color at 492 nm developed in each well.

Entities:  

Mesh:

Substances:

Year:  1991        PMID: 2035825     DOI: 10.1016/0003-2697(91)90533-y

Source DB:  PubMed          Journal:  Anal Biochem        ISSN: 0003-2697            Impact factor:   3.365


  4 in total

1.  Do Src Kinase and Caveolin Interact Directly with Na,K-ATPase?

Authors:  Eliyahu Yosef; Adriana Katz; Yoav Peleg; Tevie Mehlman; Steven J D Karlish
Journal:  J Biol Chem       Date:  2016-03-28       Impact factor: 5.157

2.  An enzyme-linked immunosorbent assay for the determination of src-family tyrosine kinase activity in breast cancer.

Authors:  G Rijksen; S S Adriaansen-Slot; G E Staal
Journal:  Breast Cancer Res Treat       Date:  1996       Impact factor: 4.872

3.  Preclinical characterization of anlotinib, a highly potent and selective vascular endothelial growth factor receptor-2 inhibitor.

Authors:  Chengying Xie; Xiaozhe Wan; Haitian Quan; Mingyue Zheng; Li Fu; Yun Li; Liguang Lou
Journal:  Cancer Sci       Date:  2018-03-25       Impact factor: 6.716

4.  The marine-derived oligosaccharide sulfate (MdOS), a novel multiple tyrosine kinase inhibitor, combats tumor angiogenesis both in vitro and in vivo.

Authors:  Jingui Ma; Xianliang Xin; Linghua Meng; Linjiang Tong; Liping Lin; Meiyu Geng; Jian Ding
Journal:  PLoS One       Date:  2008-11-20       Impact factor: 3.240

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.